Indegene Limited (NSE:INDGN)

India flag India · Delayed Price · Currency is INR
553.50
-7.90 (-1.41%)
Sep 8, 2025, 3:30 PM IST
-1.41%
Market Cap132.84B
Revenue (ttm)29.24B
Net Income (ttm)4.35B
Shares Out240.01M
EPS (ttm)18.07
PE Ratio30.64
Forward PE27.15
Dividend2.00 (0.36%)
Ex-Dividend DateJun 13, 2025
Volume229,572
Average Volume329,941
Open561.90
Previous Close561.40
Day's Range550.50 - 562.15
52-Week Range499.00 - 736.30
Betan/a
RSI45.48
Earnings DateOct 28, 2025

About Indegene

Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions. In addition, the company operates NEXT technolo... [Read more]

Sector Healthcare
Founded 1998
Employees 4,158
Stock Exchange National Stock Exchange of India
Ticker Symbol INDGN
Full Company Profile

Financial Performance

In 2024, Indegene's revenue was 28.39 billion, an increase of 9.64% compared to the previous year's 25.90 billion. Earnings were 4.07 billion, an increase of 20.79%.

Financial Statements

News

There is no news available yet.